Fig. 1 · Structure
Documents & Downloads
Moricizine Hydrochloride
Antiarrhythmic Agent
Moricizine Hydrochloride is an orally active Class I antiarrhythmic agent that primarily targets cardiac ion channels. It reduces the maximum rate of phase 0 depolarization while enhancing phase 2 and 3 repolarization rates. This compound effectively decreases action potential duration and lowers the effective refractory period, making it valuable for research in cardiac arrhythmias and electrophysiology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 29560-58-5 |
| Applications | Antiarrhythmic Agent |
| Formula | C22H26ClN3O4S |
| Molecular Weight | 463.98 |
| Synonyms | EN 313; Ethmozin; Moracizine |
| SMILES | O=C(OCC)NC(C=C1N2C(CCN3CCOCC3)=O)=CC=C1SC4=C2C=CC=C4.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.